🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation.

PMID: 41874610 · DOI: 10.1007/s00210-026-05204-0 · Naunyn-Schmiedeberg's archives of pharmacology, 2026 · Arya Kuhu Vishwapriya, Kamini Verma, Garima Sharma, Nitika Sindhu, Swati Paliwal, Smita Jain, Jaya Dwivedi, Sarvesh Pali
📄 Abstract

Epilepsy is generally described as a pathology resulting from an imbalance between excitatory and inhibitory activities. In recent years, neurotrophins have been recognized as key players in the pathophysiology of nervous system diseases. One such neurotrophin, BDNF, and its receptor, TrkB, play critical roles as epileptogenic factors that regulate neuronal hyperexcitability and synaptic plasticity. In this study, we sought to elucidate the exact mechanisms underlying the neuroprotective and antiepileptic effects of pantoprazole. The molecular docking study indicated key interactions of pantoprazole with the TrkB receptor (PDB ID: 4AT3). Furthermore, pantoprazole exhibited notable in vitro TrkB kinase inhibitory activity (IC

Confidence: 0.18 · 9 полей извлечено
Идентификация (6 полей)
Target
TrkB
0.95
Alt. target
BDNF/NT-3 growth factors receptor
0.90
Protein family
Receptor tyrosine kinase
0.90
Functional class
Kinase
0.90
Subcellular loc.
Cell membrane
0.85
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
0.00
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
0.00
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
TrkB kinase inhibitory assay (IC50 determination)
0.90
In vivo
0.00
In silico
molecular docking study with TrkB receptor (PDB ID: 4AT3)
0.90
Genetic association
0.00
Ex vivo
0.00
Animal model
0.00
Diet/model
0.00
Клиника (11 полей)
Drug
pantoprazole
0.95
Indication
epilepsy
0.90
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00